In vivo inhibition of murine leukemia and sarcoma viruses by the heteropolyanion 5-tungsto-2-antimoniate.
D000818:Animals; D000956:Antigens, Viral / Q000032:analysis; D000965:Antimony / Q000494:pharmacology*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000494:pharmacology*; D005622:Friend murine leukemia virus / Q000187:drug effects / Q000276:immunology; D017988:Gammaretrovirus / Q000187:drug effects*; D007114:Immunization; D007369:Interferon Inducers; D007939:Leukemia L1210 / Q000188:drug therapy; D009052:Leukemia Virus, Murine / Q000187:drug effects*; D007942:Leukemia, Experimental / Q000517:prevention & control*; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D008979:Moloney murine leukemia virus / Q000187:drug effects; D012509:Sarcoma / Q000382:microbiology*; D012513:Sarcoma, Experimental / Q000209:etiology; D013163:Splenomegaly / Q000517:prevention & control; D014414:Tungsten / Q000494:pharmacology*; D017973:Tungsten Compounds
D000956:Antigens, Viral; D000998:Antiviral Agents; D007369:Interferon Inducers; D017973:Tungsten Compounds; C009613:ammonium tungsten antimonate hydroxide oxide; D000965:Antimony; D014414:Tungsten